Autolus Therapeutics Plc (AUTL)

1.60 -0.02 (-1.23%) USD  |  NASDAQ  |  Dec 16, 16:00
1.60 0.00 (0.00%) After-Hours: 20:00
More

Autolus Therapeutics Research and Development Expense (TTM): 112.76M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Adaptimmune Therapeutics Plc 135.11M
Biodexa Pharmaceuticals Plc 6.352M
NuCana Plc 15.52M
Mereo BioPharma Group Plc 22.37M
Bicycle Therapeutics Plc 279.03M